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SP-0317   
Fear of recurrence and disease progression in long-term 
cancer survivors 
L. Koch1 
1German Cancer Research Center, Clinical Epidemiology and 
Aging Research, Heidelberg, Germany  
 
Purpose/Objective: Fear of recurrence (FoR), generally 
defined as the fear of the disease recurring or progressing in 
the same organ or a different area of the body, is among the 
main and most important concerns for cancer survivors. As 
opposed to anxiety disorders, FoR is not necessarily an 
irrational fear, but a reaction to a real threat. Specifically 
high levels of FoR can be dysfunctional, overwhelming 
survivors and negatively affecting their quality of life. 
Younger age and a lower educational level were repeatedly 
shown to be associated with higher FoR, whereas disease and 
treatment characteristics like stage or therapy were 
generally not found to be associated.  
Materials/Methods: Results are based on analyses of cross-
sectional data of long-term cancer survivors (>5 years post-
diagnosis) of the population-based CAESAR-study (Cancer 
Survivorship – a multi-regional population-based study). 
Survivors were recruited by six German population-based 
cancer registries. Overall, 6057 long-term breast-, colorectal, 
and prostate cancer survivors were included in the analyses. 
FoR was assessed using the short form of the Fear of 
Progression Questionnaire (FoP-Q-SF). The associations of 
age, sex, cancer type, stage, recurrence/metastases, time 
since diagnosis, education, and social support with 
moderate/high FoR were identified via multiple logistic 
regression analyses.  
Results: Even though the majority of long term cancer 
survivors reported to experience FoR in low intensity (87%), a 
significant percentage reported moderate (9%) or high (4%) 
FoR. Female survivors (Odds Ratio [OR] 3.49; p=0.002), 
survivors below 55 or 55 to 60 years of age (OR 3.32 and 2.70; 
p<0.0001 and p=0.0002), with an education of less than 10 
years (OR 2.28; p= <0.0001), having suffered from a 
recurrence or metastases (2.48; p= <0.0001), or those being 
socially isolated (OR 2.78; p<0.0001) were at a greater risk to 
experience moderate/high levels of FoR. Cancer type and 
time since diagnosis did not reach statistical significance.  
Conclusion: Even years after the initial diagnosis and 
completion of therapy, a substantial proportion of cancer 
survivors experience FoR at possibly debilitating levels. Our 
results indicate a potential vulnerability for women to 
experience FoR in high severity. Also younger and socially 
isolated survivors were at greater risk to suffer from high 
levels of FoR and should thus be monitored for high levels of 
FoR and should be offered the support needed to manage 
their fears. 
   
SP-0318   
From paediatric cancer to adult survivorship: negotiating 
psychological challenges of post-treatment  
A. Higgins1 
1Queen's University Belfast, Doctorate in Clinical Psychology 
School of Psychology, Belfast, United Kingdom  
  
With medical advances in treatment, childhood cancer has 
become more akin to a chronic illness than a terminal 
disease. With advanced treatments and increased survival 
rates there is an emerging population of young adult survivors 
who may be faced with unique developmental and 
psychosocial challenges.  
There are contradictory findings from the psychological 
evidence base as to whether survivors are at increased risk of 
psychological late effects as a result of their illness and/or 
treatment, with some studies reporting higher levels of 
psychological distress (e.g., Patenaude & Kupst, 2005) and 
others generally reporting good adjustment (Sundberg et al. 
2009). 
Irrespective of whether long-term survivors of childhood 
cancer are at an increased psychological risk, conclusive 
evidence appears to support the view that many experience 
problems in other domains such as education and career 
progression that greatly affect their quality of life.  
On entering adolescence, survivors may experience a greater 
appreciation of their previous illness and its life-threatening 
nature. This can lead to fears of relapse and elevated levels 
of post-traumatic stress (Taylor et al. 2012). Emerging 
physical late effects such as compromised fertility may 
threaten the survivor’s ability to negotiate life goals such as 
forming intimate relationships or parenting (Pivetta et al. 
2011). Outcome studies have found greater percentage of 
long-term survivors in lower skill jobs than siblings (Kirchhoff 
et al. 2011) and unemployed (Kirchhoff et al. 2010). 
Langeveld et al. (2003) found percentages of those 
employed, married or parents were less than those in a 
comparison group of participants with no history of cancer.  
Managing the combined demands of both adolescence/young 
adulthood and survivorship may mean that survivors may be 
more in need of psychological support during the post-
treatment phase of their illness than during treatment. This 
presentation will explore these psychological and 
developmental challenges for young survivors post-treatment 
while highlighting the clinical implications for the 
professionals who treat them. 
    
SP-0319   
Psycho-sexual support for pelvic radiation therapy for 
women and the impact on Quality of Life  
H. Toelen1 
1University Hospital Leuven, Gynecology, Leuven, Belgium  
 
Literature and clinical practice both indicate that women 
who are irradiated for cancer in the pelvic area do 
experience severe  long term sexual side effects from the 
treatment. Amongst others, they suffer from diminished 
desire, atrophy, difficulty in reaching an orgasm, changed 
sensitivity of the vaginal walls, premature menopause, grief 
over loss of fertility, loss of vaginal elasticity, shortened and 
more narrow vagina, stenosis and dyspareunia. 
While the side-effects such as premature menopause and loss 
of fertility are irreversible, the shortening and narrowing of 
the vaginal walls - and thus indirectly pain during a 
gynecological examination or during sexual activity - can be 
partially prevented. To prevent the shortening and narrowing 
of the vagina,  women have to dilate the vagina three times a 
week for ten minutes. This hands on treatment is a helpful 
mean to keep both  gynecological examination and sexual 
intercourse possible. It has been suggested that regular 
dilating is necessary up till two years after treatment.  
A lot of women, however, report that this preventive “work” 
is psychologically burdensome. The necessity to dilate the 
vagina with an object, for example a dilator, is experienced 
as being embarrassing and artificial. Moreover, the 
knowledge that the vagina is irradiated and sensitive makes 
women fearful to start dilating based on the expectation of 
pain. However, the alternative of natural dilating by having 
intercourse is an idea that is often felt as coming too soon 
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after the invasive treatment and the idea of having 
intercourse 3 time a week is often too much for a couple.  
Moreover, again the fear of pain makes both the women and 
her partner reluctant for even trying intercourse. 
In the literature we find that women who have been 
irradiated in the pelvic region express a need for information 
about the consequences of radiation therapy in terms of 
possible vaginal and sexual changes. Others have added that 
interventions aiming at improving (sexual) health have to 
take into account different aspects, e.g.,  the relationship, 
body-image, sexual identity and vaginal changes. Others 
revealed that women and their partners need individually 
tailored information and - practical advice about the side-
effects of the treatment including a focus on sexual 
rehabilitation. 
Based on a qualitative study, Cullen et al. (2013) formulated 
the following eight recommendations for professional 
counseling with women undergoing pelvic radiation therapy :  
  
1. Introduce the dilator in a light and straightforward 
manner 
2. Enhance dilator accessibility 
3. Introduce the vaginal dilator early on in treatment 
4. Emphasize (vaginal) health maintenance over 
intercourse as a benefit of dilator use 
5. Explore and acknowledge women’s values and 
views of sexuality 
6. Increase awareness and sensitivity to emotional 
reactions 
7. Enhance psychological educational resources for 
supporting vaginal dilator use 
8. Ensure consistent institutional practice when 
introducing the dilator 
During my talk, I will describe in more detail how these 
recommendations can be used in daily practice based on my 
experience in the University Hospital of Leuven, Belgium. 
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Purpose/Objective: Lung cancer (LC) has a significant impact 
on patients' health-related quality of life (HRQOL). This study 
aimed to investigate the correlations among patient, tumor, 
and pre-radiation therapy treatment factors and the global 
health status (GHS) and functional scales scores reported by 
LC patients before radiation therapy (RT). In addition, we 
investigated whether the pre-RT HRQOL assessment impacts 
in survival. 
Materials and Methods: We conducted a prospective 
multicentric study with a quality-of-life survey on 171 LC 
patients just before starting radiation treatment. HRQOL was 
assessed using the EORTC-QLQ-C30 (v3.0) questionnaire and 
GHS, physical (PF), role (RF), emotional (EF), cognitive (CF), 
and social functioning (SF) scores were evaluated. Several 
patient factors (age, sex, Karnofsky performance status 
[KPS], weight loss, duration of symptoms before diagnosis, 
living distances from homes to hospitals, respiratory/cardiac 
comorbidities, and smoking habits), tumor features 
(histology, stage), and other treatments before RT (induction 
chemotherapy and surgery) were considered for the analysis. 
Multivariate analyses were performed by using a logistic 
regression model, with a stepwise backward elimination 
procedure. 
Results: The median age at diagnosis was 63 years (range, 
35-89). The TNM classification was as follows: 7 I, 18 II, 129 
III, and 17 IV. The median GHS, PF, RF, EF, CF, and SF scores 
for the entire group of patients were 58%, 73%, 66%, 75%, 
83%, and 83%, respectively. In the multivariate analysis, 
patients losing weight prior to beginning RT reported lower 
GHS scores (OR 0.42; CI: 0.22-0.79; P = 0.007) and PF (OR 
0.41; CI: 0.22-0.76; P = 0.005). In terms of SF, patients 
reporting higher SF scores before treatment had a lower risk 
of mortality (OR 0.20; CI: 0.42-0.95; P = 0.043) and relapse 
(OR 0.30; CI: 0.10-0.88; P = 0.029). In addition, patients with 
non-adenocarcinoma LC reported lower SF (OR 0.31; CI: 0.14-
0.71; P = 0.005). Finally, patients who had induction 
chemotherapy reported higher EF scores (OR 2.00; CI: 1.06-
3.77; P = 0.031).  
Conclusions: Pre-RT HRQOL assessment associates with 
outcome in LC patients. Knowledge of these results may be 
used to assist the radiation oncology team to identify risk 
factors associated with lower HRQOL outcomes before RT and 
enable to make a collaborative multidisciplinary approach 
covering the specific needs for each patient.  
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Impact of urinary symptoms and incontinence on anxiety 
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Purpose/Objective: To evaluate the impact of variation of 
urinary symptoms and incontinence, prospectively evaluated 
by means of 2 validated questionnaires (QSTs), IPSS and ICIQ-
SF (hereafter ICIQ), in the first year after post-prostatectomy 
(PoP) radiotherapy (RT) end, on anxiety and depression 
(ANX/DEP) as measured by HADS (Hospital Anxiety and 
Depression Scale) questionnaire. 
Materials and Methods: In 2012 a prospective, observational, 
single Institute study for the evaluation of urinary toxicity 
from whole-pelvis RT (WPRT) was activated. This analysis 
pertains to the first 113 pts with available baseline (BSL) and 
end-RT IPSS, ICIQ and HADS QSTs. Median age was 66 years, 
median interval from prostatectomy to RT was 3.6 and 45 
months for the 63 and 50 pts treated with adjuvant and 
salvage intent, respectively. RT was delivered with static-
field IMRT, Tomotherapy and VMAT in 19, 54 and 41 pts, 
respectively, at conventional fractionation (CF, 1.8-2 Gy) in 
45 pts, and moderate hypofractionation (HYPO, median 2.35 
Gy/fraction) in 68. WPRT was delivered at 50.4 Gy/28 
fractions in CF, at 52.50 Gy/28 fractions in HYPO. Adjuvant 
androgen deprivation (AAD, median 2 years) was prescribed 
for 32 pts. The prevalence of clinically significant (score ≥8) 
anxiety (ANX≥8) and depression (DEP≥8) before (n=113), 
during (half, n=95), at RT end (n=115) and 3 (n=96), 6 (n=90) 
and 12 (n=72) months after its completion were considered. 
Wilcoxon tests were performed to find significant differences 
